ABBOTINDIA - Swing Trade Analysis with AI Signals

Last Updated Time : 19 Sept 25, 2:15 pm

Swing Trade Rating: 2.9

📊 Technical & Momentum Analysis

Price vs DMA: Trading below 50-DMA (₹32,151) and exactly at 200-DMA (₹30,979), signaling a weak trend and potential support test.

RSI (38.9): Bearish zone—momentum is weak and approaching oversold territory.

MACD (-535): Strong negative crossover—momentum is decisively bearish.

Volume: Very low (8.7K), below 1-week average—indicates poor liquidity and weak participation.

📈 Fundamental Snapshot

Metric Value Interpretation

P/E 45.4 Overvalued vs industry PE (33.4)

PEG Ratio 2.16 Expensive relative to growth

ROCE / ROE 46.2% / 35.7% Outstanding capital efficiency—long-term strength

Debt-to-Equity 0.05 Virtually debt-free—financially robust

PAT Growth (QoQ) Flat (366 Cr. vs 367 Cr.) Stable but no growth catalyst

FII/DII Change 0.00% / +0.27% Mild DII interest, no FII movement

🧠 Swing Trade Logic

Bias: Bearish short-term due to weak momentum and lack of breakout signals.

Catalyst: None visible—MACD, RSI, and volume all point to caution.

Risk: High valuation, poor liquidity, and no technical confirmation.

🎯 Optimal Entry Price

Avoid Fresh Entry: No confirmation signals. Wait for MACD reversal and RSI > 50 with volume > 15K.

🚪 Exit Strategy

If Already Holding

Target Exit: ₹32,000–₹32,500 (Resistance near 50-DMA)

Stop-Loss: ₹30,400 (Below 200-DMA and MACD base)

Selva, this setup is fundamentally strong but technically weak—better suited for long-term accumulation than tactical swing. If you're refining your pharma basket, I can help scan for low-PEG, high-volume peers with stronger breakout overlays. Ready to pivot?

Edit in a page